US-China Biomedical TechnoloUCBB
13F holders, Q2 2024 (June 30)1holders
$0.00avg. 13F price*
At the end of Q2 2024, 1 institutions reported holding US-China Biomedical Technolo (UCBB) in their 13F filings. The largest holder was Strategic Investment Solutions, Inc. ($0).
- Company
- US-China Biomedical Technolo
- CUSIP
- 91734Q104
- Latest filing quarter
- Q4 2024
History
Number of 13F holders
Total Exit/New Position Q2 2024
No earlier quarter to compare with.
Ownership 1 holders
| Strategic Investment Solutions, Inc. | 0.00% | — | 1 | $0 |
"% of holder's portfolio" is UCBB's weight in each manager's 13F, not the share of US-China Biomedical Technolo the manager owns.